• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

mBio . Impaired Cytotoxic CD8 + T Cell Response in Elderly COVID-19 Patients

tetano

Editor, Senior Moderator
mBio


. 2020 Sep 18;11(5):e02243-20.
doi: 10.1128/mBio.02243-20.
Impaired Cytotoxic CD8 [SUP]+[/SUP] T Cell Response in Elderly COVID-19 Patients


Jaana Westmeier[SUP] 1 [/SUP], Krystallenia Paniskaki[SUP] 2 [/SUP], Zehra Karak?se[SUP] 1 [/SUP], Tanja Werner[SUP] 1 [/SUP], Kathrin Sutter[SUP] 1 3 [/SUP], Sebastian Dolff[SUP] 4 [/SUP], Marvin Overbeck[SUP] 5 [/SUP], Andreas Limmer[SUP] 5 [/SUP], Jia Liu[SUP] 6 3 [/SUP], Xin Zheng[SUP] 6 3 [/SUP], Thorsten Brenner[SUP] 5 [/SUP], Marc M Berger[SUP] 5 [/SUP], Oliver Witzke[SUP] 4 [/SUP], Mirko Trilling[SUP] 1 3 [/SUP], Mengji Lu[SUP] 1 3 [/SUP], Dongliang Yang[SUP] 6 3 [/SUP], Nina Babel[SUP] 2 7 8 [/SUP], Timm Westhoff[SUP] 9 [/SUP], Ulf Dittmer[SUP] 10 3 [/SUP], Gennadiy Zelinskyy[SUP] 10 3 [/SUP]



Affiliations
Free article

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces a T cell response that most likely contributes to virus control in COVID-19 patients but may also induce immunopathology. Until now, the cytotoxic T cell response has not been very well characterized in COVID-19 patients. Here, we analyzed the differentiation and cytotoxic profile of T cells in 30 cases of mild COVID-19 during acute infection. SARS-CoV-2 infection induced a cytotoxic response of CD8[SUP]+[/SUP] T cells, but not CD4[SUP]+[/SUP] T cells, characterized by the simultaneous production of granzyme A and B as well as perforin within different effector CD8[SUP]+[/SUP] T cell subsets. PD-1-expressing CD8[SUP]+[/SUP] T cells also produced cytotoxic molecules during acute infection, indicating that they were not functionally exhausted. However, in COVID-19 patients over the age of 80 years, the cytotoxic T cell potential was diminished, especially in effector memory and terminally differentiated effector CD8[SUP]+[/SUP] cells, showing that elderly patients have impaired cellular immunity against SARS-CoV-2. Our data provide valuable information about T cell responses in COVID-19 patients that may also have important implications for vaccine development.IMPORTANCE Cytotoxic T cells are responsible for the elimination of infected cells and are key players in the control of viruses. CD8[SUP]+[/SUP] T cells with an effector phenotype express cytotoxic molecules and are able to perform target cell killing. COVID-19 patients with a mild disease course were analyzed for the differentiation status and cytotoxic profile of CD8[SUP]+[/SUP] T cells. SARS-CoV-2 infection induced a vigorous cytotoxic CD8[SUP]+[/SUP] T cell response. However, this cytotoxic profile of T cells was not detected in COVID-19 patients over the age of 80 years. Thus, the absence of a cytotoxic response in elderly patients might be a possible reason for the more frequent severity of COVID-19 in this age group than in younger patients.

Keywords: CD4+; CD8+; COVID-19; PD-1; SARS-CoV-2; aging; cytotoxic T cells; granzyme; perforin.
 
Back
Top Bottom